Quanterix (QTRX) EBIT Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.06% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 20.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 74.18% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 90.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -18.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 46.60% |
| 10 | Quanterix | 165.84 Mn | 66.57 Mn | 15.57 Mn | -56.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -56.88% |
| Dec 31, 2025 | -67.59% |
| Sep 30, 2025 | -217.71% |
| Jun 30, 2025 | -239.06% |
| Mar 31, 2025 | -73.95% |
| Dec 31, 2024 | -8.46% |
| Sep 30, 2024 | 8.28% |
| Jun 30, 2024 | -21.74% |
| Mar 31, 2024 | -43.29% |
| Dec 31, 2023 | 36.35% |
| Sep 30, 2023 | 66.25% |
| Jun 30, 2023 | 66.67% |
| Mar 31, 2023 | 41.08% |
| Dec 31, 2022 | -19.97% |
| Sep 30, 2022 | -149.16% |
| Jun 30, 2022 | -97.27% |
| Mar 31, 2022 | -83.41% |
| Dec 31, 2021 | -79.51% |
| Sep 30, 2021 | -768.70% |
| Jun 30, 2021 | -12.02% |
| Mar 31, 2021 | 16.53% |
| Dec 31, 2020 | 13.52% |
| Sep 30, 2020 | 122.24% |
| Jun 30, 2020 | -16.05% |
| Mar 31, 2020 | -25.34% |
| Dec 31, 2019 | -22.01% |
| Sep 30, 2019 | -33.69% |
| Jun 30, 2019 | -43.81% |
| Mar 31, 2019 | -30.63% |
| Dec 31, 2018 | -32.72% |
| Sep 30, 2018 | -19.96% |
| Jun 30, 2018 | -13.02% |
| Mar 31, 2018 | -18.28% |